share_log

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.61%)

bluebird bio | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(4.61%)

SEC announcement ·  02/14 06:07
牛牛AI助理已提取核心訊息
On December 29, 2023, The Vanguard Group filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of bluebird bio, Inc. common stock. The filing revealed that The Vanguard Group now beneficially owns 8,775,379 shares of bluebird bio, which represents 4.61% of the company's class of common stock. This position is a result of shared voting power over 49,185 shares and sole dispositive power over 8,670,555 shares, with an additional shared dispositive power over 104,824 shares. The Vanguard Group, headquartered in Pennsylvania, is an investment adviser and reports that the securities were acquired in the ordinary course of business, not with the purpose of changing or influencing the control of bluebird bio, Inc.
On December 29, 2023, The Vanguard Group filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of bluebird bio, Inc. common stock. The filing revealed that The Vanguard Group now beneficially owns 8,775,379 shares of bluebird bio, which represents 4.61% of the company's class of common stock. This position is a result of shared voting power over 49,185 shares and sole dispositive power over 8,670,555 shares, with an additional shared dispositive power over 104,824 shares. The Vanguard Group, headquartered in Pennsylvania, is an investment adviser and reports that the securities were acquired in the ordinary course of business, not with the purpose of changing or influencing the control of bluebird bio, Inc.
2023年12月29日,Vanguard集團向美國證券交易委員會提交了經修訂的附表13G/A,表明其持有的藍鳥生物公司普通股發生了變化。該文件顯示,Vanguard集團現在實益擁有藍鳥生物的8,775,379股股份,佔該公司普通股類別的4.61%。這一立場是對49,185股的共同投票權和對8,670,555股股票的唯一處置權的結果,另外還有對104,824股股票的共同處置權。總部位於賓夕法尼亞州的Vanguard Group是一家投資顧問,該公司報告說,這些證券是在正常業務過程中收購的,其目的不是改變或影響藍鳥生物公司的控制權。
2023年12月29日,Vanguard集團向美國證券交易委員會提交了經修訂的附表13G/A,表明其持有的藍鳥生物公司普通股發生了變化。該文件顯示,Vanguard集團現在實益擁有藍鳥生物的8,775,379股股份,佔該公司普通股類別的4.61%。這一立場是對49,185股的共同投票權和對8,670,555股股票的唯一處置權的結果,另外還有對104,824股股票的共同處置權。總部位於賓夕法尼亞州的Vanguard Group是一家投資顧問,該公司報告說,這些證券是在正常業務過程中收購的,其目的不是改變或影響藍鳥生物公司的控制權。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。